NK cells have been reported to preferentially target virus-infected tumor cells over uninfected tumor cells through NKp30 and NKp46, causing early viral clearance, limiting the reservoirs of viral replication, and consequentially compromising therapeutic outcomes [115,205,206,207]. Here, NCR3 is linked to neoplasm.